Rheumatology 2018;57:e52 doi:10.1093/rheumatology/key115 RHEUMATOLOGY Advance Access publication 5 April 2018 Global News Item Sandoz receives positive CHMP opinion for proposed biosimilar infliximab Posted on 23 March 2018 . This recommendation marks the third CHMP positive opinion granted for a Sandoz biosimilar in 12 months, . Sandoz is seeking approval of biosimilar infliximab for R R V V following Erelzi and Rixathon ; Sandoz is on track to use in all indications of its reference medicine across launch several biosimilars of major oncology and im- gastroenterology, rheumatology and dermatology munology biologics by 2020 . Positive opinion is based on a comprehensive clinical and non-clinical data package that is expected to con- Please read the full press release here: https://www.pharmi firm that Sandoz biosimilar infliximab matches the ref- web.com/pressreleases/pressrel.asp?ROW_ID=271654 erence medicine The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: email@example.com Downloaded from https://academic.oup.com/rheumatology/article-abstract/57/6/e52/4961500 by Ed 'DeepDyve' Gillespie user on 17 June 2018 NEWS ITEM
Rheumatology – Oxford University Press
Published: Apr 5, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera